The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
The addition of sitagliptin to usual care in patients with type 2 diabetes and cardiovascular disease was not associated with any change in the risk of major...
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | GLUCOSE-LOWERING DRUGS | STRATEGIES | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Triazoles - adverse effects | Double-Blind Method | Follow-Up Studies | Administration, Oral | Humans | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Pyrazines - therapeutic use | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - blood | Heart Diseases - etiology | Heart Diseases - epidemiology | Pyrazines - adverse effects | Cardiovascular Diseases - mortality | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Heart Failure - etiology | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Triazoles - therapeutic use | Type 2 diabetes | Care and treatment | Usage | Clinical trials | Influence | Sitagliptin | Dosage and administration | Cardiovascular diseases | Myocardial infarction | Cerebral infarction | Stroke | Inhibitor drugs | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Side effects | Pancreatic cancer | Hemoglobin | Diabetes | Health risk assessment | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | GLUCOSE-LOWERING DRUGS | STRATEGIES | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Triazoles - adverse effects | Double-Blind Method | Follow-Up Studies | Administration, Oral | Humans | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Pyrazines - therapeutic use | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - blood | Heart Diseases - etiology | Heart Diseases - epidemiology | Pyrazines - adverse effects | Cardiovascular Diseases - mortality | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Heart Failure - etiology | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Triazoles - therapeutic use | Type 2 diabetes | Care and treatment | Usage | Clinical trials | Influence | Sitagliptin | Dosage and administration | Cardiovascular diseases | Myocardial infarction | Cerebral infarction | Stroke | Inhibitor drugs | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Side effects | Pancreatic cancer | Hemoglobin | Diabetes | Health risk assessment | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2009, Volume 68, Issue 6, pp. 938 - 947
Objective:In a multicentre study to explore the effects of licofelone as a disease-modifying osteoarthritis drug in comparison with naproxen in patients with...
RISK-FACTORS | RADIOGRAPHIC CHANGES | MANAGEMENT | RECOMMENDATIONS | GLUCOSAMINE SULFATE | VOLUME | SYMPTOMS | RHEUMATOLOGY | 3-YEAR | PROGRESSION | HIP | Follow-Up Studies | Humans | Middle Aged | Male | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Female | Pyrroles - therapeutic use | Lipoxygenase Inhibitors | Antirheumatic Agents - therapeutic use | Naproxen - adverse effects | Double-Blind Method | Drug Administration Schedule | Knee Joint - diagnostic imaging | Treatment Outcome | Chi-Square Distribution | Naproxen - therapeutic use | Osteoarthritis, Knee - diagnostic imaging | Radiography | Cartilage, Articular - pathology | Magnetic Resonance Imaging | Image Processing, Computer-Assisted | Osteoarthritis, Knee - pathology | Aged | Pain Measurement | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - therapeutic use | Osteoarthritis, Knee - drug therapy | Knee | Usage | Magnetic resonance imaging | Naproxen | Patient outcomes | Physiological aspects | Research | Drug therapy | Health aspects | Osteoarthritis | Diseases | Side effects | Arthritis | Metabolic disorders | Index Medicus
RISK-FACTORS | RADIOGRAPHIC CHANGES | MANAGEMENT | RECOMMENDATIONS | GLUCOSAMINE SULFATE | VOLUME | SYMPTOMS | RHEUMATOLOGY | 3-YEAR | PROGRESSION | HIP | Follow-Up Studies | Humans | Middle Aged | Male | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Female | Pyrroles - therapeutic use | Lipoxygenase Inhibitors | Antirheumatic Agents - therapeutic use | Naproxen - adverse effects | Double-Blind Method | Drug Administration Schedule | Knee Joint - diagnostic imaging | Treatment Outcome | Chi-Square Distribution | Naproxen - therapeutic use | Osteoarthritis, Knee - diagnostic imaging | Radiography | Cartilage, Articular - pathology | Magnetic Resonance Imaging | Image Processing, Computer-Assisted | Osteoarthritis, Knee - pathology | Aged | Pain Measurement | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - therapeutic use | Osteoarthritis, Knee - drug therapy | Knee | Usage | Magnetic resonance imaging | Naproxen | Patient outcomes | Physiological aspects | Research | Drug therapy | Health aspects | Osteoarthritis | Diseases | Side effects | Arthritis | Metabolic disorders | Index Medicus
Journal Article
The Lancet, ISSN 0140-6736, 10/1993, Volume 342, Issue 8875, pp. 821 - 828
Survival after acute myocardial infarction has been enhanced by treatment with thrombolytic agents, aspirin, and β-adrenoceptor blockade. However, there...
VENTRICULAR ENLARGEMENT TRIAL | MEDICINE, GENERAL & INTERNAL | COMPLICATIONS | INHIBITION | ENALAPRIL | Heart failure | Drug therapy | Heart attack | Medical research | Cardiovascular disease | Mortality | Myocardial infarction | Therapy | Heart attacks | Medical services | Clinical trials | Risk | Antagonists | Subgroups | Reduction | Randomization | Motivation | Peptidyl-dipeptidase A | Heart diseases | Cerebral infarction | Aspirin | Stroke | Risk groups | Oral administration | Risk reduction | Survival | Patients | Thrombolysis | Morbidity | Inhibitors | Angiotensin | Fatalities | Adrenergic receptors | Infarction | Hemodynamics | Risk management
VENTRICULAR ENLARGEMENT TRIAL | MEDICINE, GENERAL & INTERNAL | COMPLICATIONS | INHIBITION | ENALAPRIL | Heart failure | Drug therapy | Heart attack | Medical research | Cardiovascular disease | Mortality | Myocardial infarction | Therapy | Heart attacks | Medical services | Clinical trials | Risk | Antagonists | Subgroups | Reduction | Randomization | Motivation | Peptidyl-dipeptidase A | Heart diseases | Cerebral infarction | Aspirin | Stroke | Risk groups | Oral administration | Risk reduction | Survival | Patients | Thrombolysis | Morbidity | Inhibitors | Angiotensin | Fatalities | Adrenergic receptors | Infarction | Hemodynamics | Risk management
Journal Article
BMJ: British Medical Journal, ISSN 0959-8138, 10/2011, Volume 343, Issue 7829, pp. 889 - 893
SUMMARY POINTS Systematic reviews should carefully consider the potential limitations of the studies included The Cochrane Collaboration has developed a new...
Statistical bias | Health outcomes | Research biases | Handbooks | Clinical trials | Experimentation | Selection bias | Research tools | RESEARCH METHODS & REPORTING | Empirical evidence | Research methods | MEDICINE, GENERAL & INTERNAL | QUALITY | MOLECULAR-WEIGHT HEPARIN | Risk Assessment | Research Design | Bias | Humans | Randomized Controlled Trials as Topic - standards
Statistical bias | Health outcomes | Research biases | Handbooks | Clinical trials | Experimentation | Selection bias | Research tools | RESEARCH METHODS & REPORTING | Empirical evidence | Research methods | MEDICINE, GENERAL & INTERNAL | QUALITY | MOLECULAR-WEIGHT HEPARIN | Risk Assessment | Research Design | Bias | Humans | Randomized Controlled Trials as Topic - standards
Journal Article
5.
Full Text
Efficient Annealing of Radiation Damage Near Grain Boundaries via Interstitial Emission
Science, ISSN 0036-8075, 3/2010, Volume 327, Issue 5973, pp. 1631 - 1634
Although grain boundaries can serve as effective sinks for radiation-induced defects such as interstitials and vacancies, the atomistic mechanisms leading to...
Grain boundaries | Single crystals | Annealing | Energy | Materials | Atoms | Radiation tolerance | Irradiation | Materials science | Reports | Radiation damage | IRRADIATION | DEFECTS | CLUSTERS | METALS | MULTIDISCIPLINARY SCIENCES | DYNAMICS | IRON | COPPER | SIMULATION | MICROSTRUCTURE | Research | Properties | Atoms & subatomic particles | Copper | Radiation | nuclear (including radiation effects), defects, mechanical behavior, materials and chemistry by design, synthesis (novel materials), synthesis (scalable processing) | MATERIALS SCIENCE
Grain boundaries | Single crystals | Annealing | Energy | Materials | Atoms | Radiation tolerance | Irradiation | Materials science | Reports | Radiation damage | IRRADIATION | DEFECTS | CLUSTERS | METALS | MULTIDISCIPLINARY SCIENCES | DYNAMICS | IRON | COPPER | SIMULATION | MICROSTRUCTURE | Research | Properties | Atoms & subatomic particles | Copper | Radiation | nuclear (including radiation effects), defects, mechanical behavior, materials and chemistry by design, synthesis (novel materials), synthesis (scalable processing) | MATERIALS SCIENCE
Journal Article
Microbiology and Molecular Biology Reviews, ISSN 1092-2172, 03/2009, Volume 73, Issue 1, pp. 71 - 133
Article Usage Stats Services MMBR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
REDUCING ENRICHMENT CULTURE | DENITRIFYING PSEUDOMONAS SP | AZOARCUS SP CIB | P-CRESOL METHYLHYDROXYLASE | SP STRAIN-T | BACTERIUM THAUERA-AROMATICA | MICROBIOLOGY | GLUTARYL-COA DEHYDROGENASE | PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE | MOLYBDENUM-CONTAINING HYDROXYLASES | BENZOYL-COENZYME-A | Amino Acids, Aromatic - metabolism | Anaerobiosis | Biodegradation, Environmental | Hydrocarbons, Aromatic - metabolism | Multigene Family | Photophosphorylation - genetics | Fermentation - genetics | Ecosystem | Genomics | Bacteria, Anaerobic - metabolism | Bacteria, Anaerobic - genetics | Environmental Pollutants - metabolism | Anaerobic bacteria | Aromatic compounds | Analysis | Physiological aspects | Genetic aspects | Chemical properties | Research | Gene expression | Index Medicus | Reviews
REDUCING ENRICHMENT CULTURE | DENITRIFYING PSEUDOMONAS SP | AZOARCUS SP CIB | P-CRESOL METHYLHYDROXYLASE | SP STRAIN-T | BACTERIUM THAUERA-AROMATICA | MICROBIOLOGY | GLUTARYL-COA DEHYDROGENASE | PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE | MOLYBDENUM-CONTAINING HYDROXYLASES | BENZOYL-COENZYME-A | Amino Acids, Aromatic - metabolism | Anaerobiosis | Biodegradation, Environmental | Hydrocarbons, Aromatic - metabolism | Multigene Family | Photophosphorylation - genetics | Fermentation - genetics | Ecosystem | Genomics | Bacteria, Anaerobic - metabolism | Bacteria, Anaerobic - genetics | Environmental Pollutants - metabolism | Anaerobic bacteria | Aromatic compounds | Analysis | Physiological aspects | Genetic aspects | Chemical properties | Research | Gene expression | Index Medicus | Reviews
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix499 - ix527
Journal Article